OBJECTIVE
Although type-2 diabetes is considered a comorbid condition of gout, the uricosuric effect of glycosuria or the impaired inflammatory response in diabetes may actually reduce the future risk of gout. We evaluated the impact of diabetes on the future risk of developing gout.
METHODS
We conducted a case-control study nested in a UK general practice database (the Health Improvement Network) by identifying all incident cases of gout (N=24,768) and randomly sampled 50,000 controls who were 20–79 years between 2000 and 2007. We examined the independent effect of type-1 and type-2 diabetes on the development of incident gout.
RESULTS
After adjusting for age, sex, body mass index, general practitioner visits, smoking, alcohol intake, ischemic heart disease, and presence of cardiovascular risk factors, the relative risk (RR) for incident gout among diabetes patients, as compared with individuals with no diabetes was 0.67 (95% CI, 0.63 to 0.71). The multivariate RRs with the duration of diabetes of 0–3, 4–9, and ≥ 10 years were 0.81 (95% CI, 0.74 to 0.90), 0.67 (95% CI, 0.61 to 0.73), and 0.52 (95% CI, 0.46 to 0.58), respectively. The inverse association was stronger with type 1 diabetes than with type 2 diabetes (multivariate RR, 0.33 vs. 0.69; P value < 0.001). The inverse association was stronger among men than women (multivariate RR [95% CI], 0.59 [0.53 to 0.64] vs. 0.90 [0.80 to 1.00]; P value for interaction <0.001).
CONCLUSIONS
Individuals with diabetes are at a lower future risk of gout independent of other risk factors. These data provide support for a substantial role of the pathophysiology associated with diabetes (e.g. the uricosuric effect of glycosuria and the impaired inflammatory response) against the risk of developing gout.